Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 3 Sponsors

Jun 23, 2026 · Assembly

Reported out of Assembly Committee, 2nd Reading

Jun 18, 2026 · Assembly

Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee

Jan 13, 2026 · Assembly

Introduced, Referred to Assembly Health Committee

PASSAGE PROBABILITY

5.2% Unlikely

Why this number

Stage base Floor Consideration — base rate 18%, measured from NJ's completed sessions
Momentum +1 55/100 from the pace of recorded action
Time since last action -14 109 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.